ALZ-NET Study
ALZ-NET is a voluntary patient registry that collects information on treatments for Alzheimer’s disease from patients being evaluated for or treated with novel FDA-approved Alzheimer’s therapies. ALZ-NET aims to be a resource for evidence-gathering, information sharing, and education across clinical and research communities to support and improve care of individuals living with Alzheimer’s disease.
For more information about the ALZ-NET study, and to see if you may qualify, please click HERE or email ResearchNCNE@myneurodr.com / call 781-551-5812 opt.2.